Analysis of Clinical Characteristics of Patients with Recurrent Cytomegalovirus Retinitis after Hematopoietic Stem Cell Transplantation

被引:2
|
作者
Wang, Xiaona [1 ]
Lu, Yao [1 ]
Li, Haiping [1 ]
Ma, Zhizhong [1 ]
Hong, Jing [1 ]
Wang, Changguan [1 ]
机构
[1] Peking Univ Third Hosp, Dept Ophthalmol, Beijing Key Lab Restorat Damaged Ocular Nerve, Beijing 100191, Peoples R China
来源
JOURNAL OF PERSONALIZED MEDICINE | 2023年 / 13卷 / 04期
关键词
hematopoietic stem cell transplantation; cytomegalovirus retinitis; recurrence; wide-angle fundus photography; optical coherence tomography; polymerase chain reaction; CD4; RISK-FACTORS; COMPLICATIONS; THERAPY; ERA;
D O I
10.3390/jpm13040639
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To analyze and summarize the clinical and imaging characteristics of patients with cytomegalovirus retinitis (CMVR) relapse after hematopoietic stem cell transplantation (HSCT). Methods: This retrospective case series study recruited patients with CMVR after HSCT. The study compared the patients with stable lesions and CMV-negative aqueous humor after treatment with those with relapse lesions and a CMV DNA load in aqueous humor which had increased again after treatment. The observation indexes were basic clinical information, best-corrected visual acuity, wide-angle fundus photography, optical coherence tomography (OCT), blood CD4(+) T lymphocyte count, and aqueous humor CMV load of the patients. We summarized the data and statistically analyzed the differences between the relapse and non-relapse groups, as well as the correlations of the observed indicators. Results: The study recruited 52 patients with CMVR (82 eyes) after HSCT, of whom 11 patients (15 eyes) had recurrence after treatment (21.2%). The recurrence interval was 6.4 +/- 4.9 months. The final best-corrected visual acuity of recurrent patients was 0.3 +/- 0.3. The number of CD4(+) T lymphocytes in recurrence patients at the time of onset was 126.7 +/- 80.2/mm(3). The median CMV DNA load detected in aqueous humor at the time of recurrence was 8.63 x 10(3) copies/mL. There was a significant difference in the CD4(+) T lymphocyte count between the recurrence and the non-recurrence groups at onset. The onset of visual acuity in recurrence patients was significantly correlated with final visual acuity and recurrence lesion area. The fundus of recurred CMVR showed increased marginal activity of the original stable lesion. Concurrently, yellow-white new lesions appeared around the stable, atrophic, and necrotic lesions. OCT showed new diffuse hyperreflexic lesions in the retinal neuroepithelial layer near the old lesions. Inflammatory punctate hyperreflexes were observed in the vitreous, with vitreous liquefaction and contraction. Conclusion: This study suggests that the clinical features, fundus manifestations, and imaging features of CMVR recurrence after HSCT are different from those at the initial onset. Patients should be closely followed up after their condition is stable to be alert for CMVR recurrence.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Clinical characteristics of and risk factors for herpes zoster after hematopoietic stem cell transplantation
    Leung, AYH
    Yuen, KY
    Cheng, VCC
    Lie, AKW
    Liang, R
    Kwong, YL
    HAEMATOLOGICA, 2002, 87 (04) : 444 - 446
  • [42] Vaccination Recommendations and Clinical Characteristics of Children after Allogeneic Hematopoietic Stem Cell Transplantation
    Cai, Jiaoyang
    Chen, Wenjuan
    Zhang, Hua
    Chen, Jing
    Fei, Yi
    Cao, Qing
    BLOOD, 2023, 142
  • [43] Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantation
    Huang, Qin
    Reddi, Deepti
    Chu, Peiguo
    Snyder, David S.
    Weisenburger, Dennis D.
    HUMAN PATHOLOGY, 2014, 45 (12) : 2404 - 2410
  • [44] The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation
    Webb, Brandon J.
    Harrington, Rachel
    Schwartz, Jason
    Kammerer, Jennifer
    Spalding, James
    Lee, Edward
    Dodds, Bart
    Kaufusi, Stephanie
    Goodman, Bruce E.
    Firth, Sean D.
    Martin, Greta
    Sorensen, Jeffrey
    Hoda, Daanish
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (05)
  • [45] Clinical characteristics in the misdiagnosis of cytomegalovirus retinitis: A retrospective analysis of eight patients
    Du, Kui-Fang
    Huang, Xiao-Jie
    Chen, Chao
    Kong, Wen-Jun
    Xie, Lian-Yong
    Wei, Wen-Bin
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (10) : 3596 - 3602
  • [46] Use of Valacyclovir for the Treatment of Cytomegalovirus Antigenemia after Hematopoietic Stem Cell Transplantation
    Ong, Shin-Yeu
    Ha Thi Thu Truong
    Ho, Aloysius Y.
    Linn, Yeh Ching
    Goh, Yeow-Tee Y. T.
    Diong, Colin Phipps
    Loh, Yvonne
    Hwang, William Y. K.
    BLOOD, 2014, 124 (21)
  • [47] Endoscopic diagnosis of cytomegalovirus gastritis after allogeneic hematopoietic stem cell transplantation
    Yasuo Kakugawa
    Masahiro Kami
    Takahisa Matsuda
    Yutaka Saito
    Sung-Won Kim
    Takahiro Fukuda
    Shin-ichiro Mori
    Tadakazu Shimoda
    Ryuji Tanosaki
    Daizo Saito
    World Journal of Gastroenterology, 2010, 16 (23) : 2907 - 2912
  • [48] High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation
    Asano-Mori, Y
    Oshima, K
    Sakata-Yanagimoto, M
    Nakagawa, M
    Kandabashi, K
    Izutsu, K
    Hangaishi, A
    Motokura, T
    Chiba, S
    Kurokawa, M
    Hirai, H
    Kanda, Y
    BONE MARROW TRANSPLANTATION, 2005, 36 (09) : 813 - 819
  • [49] An update on the treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
    Maffini, Enrico
    Busca, Alessandro
    Costa, Cristina
    Giaccone, Luisa
    Cerrano, Marco
    Curtoni, Antonio
    Cavallo, Rossana
    Bruno, Benedetto
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (11) : 937 - 945
  • [50] High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation
    Y Asano-Mori
    K Oshima
    M Sakata-Yanagimoto
    M Nakagawa
    K Kandabashi
    K Izutsu
    A Hangaishi
    T Motokura
    S Chiba
    M Kurokawa
    H Hirai
    Y Kanda
    Bone Marrow Transplantation, 2005, 36 : 813 - 819